Cutler Group LLC / CA - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 168 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$59
-98.5%
5,210
+768.3%
0.01%
Q2 2022$4,000
+300.0%
600
-88.0%
0.00%
Q1 2021$1,000
-99.3%
5,000
-61.3%
0.00%
-100.0%
Q4 2020$139,000
+1637.5%
12,911
+6355.5%
0.01%
+600.0%
Q3 2019$8,000
-74.2%
200
-60.0%
0.00%
-66.7%
Q2 2019$31,000
-64.0%
500
-86.9%
0.00%
-62.5%
Q4 2018$86,000
-53.3%
3,821
-45.4%
0.01%
-38.5%
Q3 2018$184,000
-20.3%
7,000
-50.5%
0.01%
-27.8%
Q2 2018$231,000
+2787.5%
14,150
+1130.4%
0.02%
+1700.0%
Q1 2018$8,000
-27.3%
1,150
+228.6%
0.00%
Q4 2017$11,000
-91.9%
350
-97.5%
0.00%
-100.0%
Q3 2017$136,000
-4.9%
14,013
-36.4%
0.01%0.0%
Q2 2017$143,000
+20.2%
22,028
-60.6%
0.01%0.0%
Q1 2017$119,000
-89.4%
55,915
-33.9%
0.01%
-87.5%
Q4 2016$1,118,000
+23.0%
84,610
+24.5%
0.04%0.0%
Q3 2016$909,000
+782.5%
67,935
+378.4%
0.04%
+700.0%
Q2 2016$103,000
-8.0%
14,200
+0.0%
0.01%
-28.6%
Q1 2016$112,000
+83.6%
14,198
+59.5%
0.01%
+75.0%
Q4 2015$61,0008,9000.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2017
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 727,426$25,932,7374.72%
RTW INVESTMENTS, LP 5,405,089$192,691,4234.07%
First Light Asset Management, LLC 1,125,032$40,107,3913.81%
CHI Advisors LLC 215,000$7,664,7503.04%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 250,052$8,914,3543.00%
SPHERA FUNDS MANAGEMENT LTD. 259,135$9,238,1631.68%
Rock Springs Capital Management LP 1,476,441$52,635,1221.41%
SUVRETTA CAPITAL MANAGEMENT, LLC 679,459$24,222,7131.31%
Privium Fund Management B.V. 115,241$4,108,3411.22%
SECTOR GAMMA AS 115,166$4,105,6681.05%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders